C4 Therapeutics (CCCC) Interest & Investment Income (2020 - 2025)
Historic Interest & Investment Income for C4 Therapeutics (CCCC) over the last 6 years, with Q3 2025 value amounting to $2.2 million.
- C4 Therapeutics' Interest & Investment Income fell 3722.75% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year decrease of 3249.6%. This contributed to the annual value of $14.4 million for FY2024, which is 4705.46% up from last year.
- According to the latest figures from Q3 2025, C4 Therapeutics' Interest & Investment Income is $2.2 million, which was down 3722.75% from $2.5 million recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Interest & Investment Income ranged from a high of $3.9 million in Q1 2024 and a low of $69000.0 during Q2 2021
- For the 5-year period, C4 Therapeutics' Interest & Investment Income averaged around $1.9 million, with its median value being $2.2 million (2023).
- In the last 5 years, C4 Therapeutics' Interest & Investment Income tumbled by 7220.08% in 2021 and then surged by 115661.76% in 2022.
- Over the past 5 years, C4 Therapeutics' Interest & Investment Income (Quarter) stood at $136000.0 in 2021, then skyrocketed by 1156.62% to $1.7 million in 2022, then soared by 72.62% to $2.9 million in 2023, then increased by 10.75% to $3.3 million in 2024, then crashed by 31.25% to $2.2 million in 2025.
- Its Interest & Investment Income stands at $2.2 million for Q3 2025, versus $2.5 million for Q2 2025 and $2.8 million for Q1 2025.